132
http://www.DGS-PraxisLeitlinien.deNr.
Nachweis
100
Freye E, Levy JV, Braun D. Effervescent morphine results in faster relief of breakthrough
pain in patients compared to immediate release morphine sulfate tablet. Pain Pract 2007;
7(4): 324-331.
101
Freye E. Opioide in der Medizin. Springer Verlag Heidelberg, 8. Auflage, 2010;
102
Gamal G, Helaly M, Labib YM. Superior hypogastric block: transdiscal versus classic poste-
rior approach in pelvic cancer pain. Clin J Pain 2006; 22(6): 544-547.
103
García de Paredes ML, del Moral González F, Martínez del Prado P, Martí Ciriquián JL, En-
rech Francés S, Cobo Dols M, Esteban González E, Ortega Granados AL, Majem Tarruella
M, Cumplido Burón JD, Gascó Hernández A, López Miranda E, Ciria Santos JP, de Castro
Carpeño FJ. First evidence of oncologic neuropathic pain prevalence after screening 8615
cancer patients. Results of the On study. Ann Oncol 2011; 22(4): 924-930.
104
Gartner R, Kroman N, Callesen T, Kehlet H. Multimodal prevention of pain, nausea and
vomiting after breast cancer surgery. Minerva Anestesiol 2010; 76(10): 805-813.
105
Gatti A, Longo G, Sabato E, Sabato AF. Long-term controlled-release oxycodone and
pregabalin in the treatment of non-cancer pain: an observational study. Eur Neurol 2011;
65(6): 317-322.
106
Gatti A, Reale C, Luzi M, Canneti A, Mediati RD, Vellucci R, Mammucari M, Sabato AF.
Effects of opioid rotation in chronic pain patients: ORTIBARN study. Clin Drug Investig
2010; 30 Suppl 2: 39-47.
107
Gatti A, Reale C, Occhioni R, Luzi M, Canneti A, De Polo C, Gubernari M, Mammucari M,
Fabrizio Sabato A. Standard therapy with opioids in chronic pain management : ORTIBER
study. Clin Drug Investig 2009; 29 Suppl 1: 17-23.
108
Gazoni FM, Pouratian N, Nemergut EC. Effect of ropivacaine skull block on perioperative
outcomes in patients with supratentorial brain tumors and comparison with remifentanil:
a pilot study. J Neurosurg 2008; 109(1): 44-49.
109
GEISSLINGER, G. Opioide differenziert einsetzen, STK-Zeitschrift für angewandte
Schmerztherapie 3/99; 4-6. 2/00; 7-9.
110
Good P, Jackson K, Brumley D, Ashby M. Intranasal sufentanil for cancer-associated
breakthrough pain. Palliat Med 2009; 23(1): 54-58.
111
Goodchild CS, Nelson J, Cooke I, Ashby M, Jackson K. Combination therapy with flupirtine
and opioid: open-label case series in the treatment of neuropathic pain associated with
cancer. Pain Med 2008; 9(7): 939-949.
112
Gralow J, Tripathy D. Managing metastatic bone pain: the role of bisphosphonates (Re-
view). Journal of Pain and Symptom Management 2007; 33 (4), 462-472.
113
Greco MT, Corli O, Montanari M, Deandrea S, Zagonel V, Apolone G. Epidemiology and
pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients:
results from the Cancer Pain Outcome Research Study Group. Clin J Pain 2011; 27(1):
9-18.
114
Greco MT, Deandrea S, Corli O, Montanari M, Caraceni A, Apolone G. [Effects of transder-
mal buprenorphine in cancer patients. Results from the Cancer Pain Outcome Research
(CPOR) Study Group]. Recenti Prog Med 2008; 99(11): 538-551.
Literaturverzeichnis